{
  "docId": "019de073-4386-7700-b700-92166fcbcd7c",
  "docSlug": "fd316ea801ff13186537922fd8d6b6b2",
  "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 28,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "customer_logos",
  "function": "cite_precedent",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide categorizes partnerships into clinical stage and pre-clinical programs, detailing the nature of the collaboration (e.g., cost/profit share, royalties).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/12",
  "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c",
  "deckJsonHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c.json",
  "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "image",
      "text": "Logos of Pfizer, Fosun Pharma, Regeneron, Genentech, Genmab, Sanofi, University of Pennsylvania, Bill & Melinda Gates Foundation, Genevant",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd89ca6a-4256-4381-ac09-011d4370a7fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.225
      },
      "kind": "paragraph",
      "text": "Collaborations for clinical stage programs",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77f306bc-8763-45e8-9d11-35577549cdd7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.76,
        "x": 0.12,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "Pre-clinical collaborations",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3d77847-b60c-4319-b8f6-2e8bb824a3bd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.08,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "50:50 cost & profit share refers to terms of Pfizer collaboration only (world-wide ex-China)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6623860-1c53-48db-9fb0-7c116b949421",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.5,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "We Collaborate with Global Leaders in Our Industry",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b060e99a-5bc4-49a5-8a4e-261a84f0ebb2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience frame",
      "slug": "audience-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "3f9b20f9-43b9-4b8d-bdd0-082554fb93e6",
      "evidence": "Collaborations for clinical stage programs",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 28,
      "from": 6,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976",
      "evidence": "The presentation follows a 'why-what-how' structure",
      "position": 0,
      "objective": "Why BioNTech's approach is necessary and beneficial",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}